Tuesday, October 17, 2006

FDA approves new drug for Type II diabetes

Here’s a mixed bag of news for those with Type II diabetes. The
FDA has approved a new diabetes drug.

According to the Houston Chronicle story:

“The Food and Drug Administration said it approved Januvia, which enhances the body's own ability to lower blood sugar levels, after clinical trials showing the new pill works just as well as older diabetes drugs, but with fewer side effects like weight gain. The drug is made by Merck and Co. Inc.”

“The new drug's cost may limit its use, however. Merck did not immediately disclose what it would charge for Januvia, but it is expected to cost between $3 and $6 a day. Older diabetes drugs can cost 50 cents a day.”

“Januvia, also known as sitagliptin phosphate, works with a one-two punch: It increases levels of a hormone that triggers the pancreas to produce more insulin to process blood sugar while simultaneously signaling the liver to quit making glucose. The pill does that by blocking production of an enzyme, called DPP-4, that normally inactivates that hormone.“

So, take the news for what it is worth. It handles Type II diabetes with less side effects than existing medications, but at a higher cost per dose.

1 comment:

Sharon said...

Hi,

7.9% of the United States population is suffering from a form of Diabetes. That is over 23 million people! Now, more than ever, it is important for organizations such as yourself. We here, at Disease.com (a site dedicated towards disease and their treatments), believe in the work you do and would like to coincide for the fight against diabetes. If you could, please list us as a resource or host our social book mark button, it would be much appreciated. Separately, we can make advancements, but together we can find a cure.
If you need more information please email me back with the subject line as your URL.

Thank You,
Sharon Vegoe
Disease.com